Q4 2021 Chemomab Therapeutics Ltd Earnings Call Transcript
Greetings. Welcome to Chemomab's fourth-quarter and full-year 2021 earnings call. (Operator Instructions) Please note this conference is being recorded.
I will now turn the conference over to Barbara Lindheim, Vice President of Investor Relations. Thank you. You may begin.
Welcome to the Chemomab Therapeutics 2021 fourth-quarter and full-year results conference call. Thank you for attending.
I am Barbara Lindheim, Consulting Vice President of Communications at Chemomab. With me today are Dale Pfost, our Chairman and CEO; Don Marvin, CFO, Chief Operating Officer and the Executive Vice President; Dr. David Wiener, Chemomab Interim Chief Medical Officer; and Dr. Adi Mor, our Co-Founder and Chief Scientific Officer.
Before I turn the call over to Dale, please take note of our forward-looking statements. Today's call may contain forward-looking statements, which may be identified by words such as may, could, will, expect, intend,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |